PRIME THERAPEUTICS for PRIME THERAPEUTICS
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Notice of benefit and payment parameters for 2014 proposed rule - Cost sharing subsidy reconcilliation methodology Essential health benefits proposed rule - pharmacy benefits Establishment of the multi-state plan program - pharmacy benefit manager transparency requirements Pharmacy compounding
| Lobbyist | Covered position, as disclosed |
|---|---|
| STACEY FAHRNER | — |
Pharmacy PHA
Notice of benefit and payment parameters for 2014 proposed rule - Cost sharing subsidy reconcilliation methodology Essential health benefits proposed rule - pharmacy benefits Establishment of the multi-state plan program - pharmacy benefit manager transparency requirements Pharmacy compounding
| Lobbyist | Covered position, as disclosed |
|---|---|
| STACEY FAHRNER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.